Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats

碩士 === 國防醫學院 === 生物及解剖學研究所 === 91 === Serotonin transporters (SERT) are target-sites for many antidepressants. Most reviewers acknowledge that there is a great demand for a highly selective SERT radioligand for SPECT. A radioligand for SPECT imaging with high selectivity for SERT would make it possi...

Full description

Bibliographic Details
Main Authors: Hui-Ling,Huang, 黃惠伶
Other Authors: Jiang-Chuan, Liu
Format: Others
Language:zh-TW
Published: 2003
Online Access:http://ndltd.ncl.edu.tw/handle/89730871483160934480
id ndltd-TW-091NDMC0589006
record_format oai_dc
spelling ndltd-TW-091NDMC05890062016-06-22T04:20:05Z http://ndltd.ncl.edu.tw/handle/89730871483160934480 Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats 單側巴金森氏症大白鼠腦中之[123I]ADAM生物分佈情形 Hui-Ling,Huang 黃惠伶 碩士 國防醫學院 生物及解剖學研究所 91 Serotonin transporters (SERT) are target-sites for many antidepressants. Most reviewers acknowledge that there is a great demand for a highly selective SERT radioligand for SPECT. A radioligand for SPECT imaging with high selectivity for SERT would make it possible to monitor at-risk individuals with depression. However, no such radioligand is currently available for routine SPECT imaging. Recently, a highly selective radioligand, ADAM(2-((2-((dimethylamino)methyl))phenyl)thio)-5-iodophenylamine) was developed. Recent reports of [123I]ADAM for SPECT imaging in vivo showed its prominent uptake in several brain regions, which parallelled to known SERT areas and suggested that the [123I]ADAM may be useful for SPECT imaging of SERT binding sites in the human brain. In this study, we investigated the biodistributions of [123I]ADAM in brains of hemiparkinsonian rats and examined if the serotonergic system would be changed. At two hours after [123I]ADAM injection, the animals were sacrificed and the autoradiography was performed. In normal rats, there are high uptakes of [123I]ADAM in the hippocampus, hypothalamus, striatum, olfactory tubercle, substantia nigra, dorsal raphe, median raphe, and thalamus, as in areas possessing known SERT. A hemiparkinsonisonisum was induced by injection of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle of rats. Two weeks later, methamphetamine-induced rotation behavior was evaluated. We choose three rats that performed drug-induced rotation over 300 circles. We also examined dopaminergic neurons in hemiparkinsonian rats by tyrosine hydroxylase immunohistochemistry which showed decreased dopaminergic neurons in the substantia nigra of hemiparkinsonian rats. The autoradiographical images also demonstrated that the [123I]ADAM uptakes in the hippocampus, hypothalamus, striatum, olfactory tubercle, dorsal raphe, median raphe, and thalamus of hemiparkinsonian rats were significantly lower than those of normal rats. In conclusion, we proposed that the novel ligand [123I]ADAM can be highly selective for SERT. Through this high selective radioligand [123I]ADAM, a significant decreased the serotonin transporters in several brain tissues was found in hemiparkinsonian rats. Jiang-Chuan, Liu Ching-Hsiang, Wu Wen-Shen, Huang 劉江川 吳慶祥 黃文盛 2003 學位論文 ; thesis 81 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國防醫學院 === 生物及解剖學研究所 === 91 === Serotonin transporters (SERT) are target-sites for many antidepressants. Most reviewers acknowledge that there is a great demand for a highly selective SERT radioligand for SPECT. A radioligand for SPECT imaging with high selectivity for SERT would make it possible to monitor at-risk individuals with depression. However, no such radioligand is currently available for routine SPECT imaging. Recently, a highly selective radioligand, ADAM(2-((2-((dimethylamino)methyl))phenyl)thio)-5-iodophenylamine) was developed. Recent reports of [123I]ADAM for SPECT imaging in vivo showed its prominent uptake in several brain regions, which parallelled to known SERT areas and suggested that the [123I]ADAM may be useful for SPECT imaging of SERT binding sites in the human brain. In this study, we investigated the biodistributions of [123I]ADAM in brains of hemiparkinsonian rats and examined if the serotonergic system would be changed. At two hours after [123I]ADAM injection, the animals were sacrificed and the autoradiography was performed. In normal rats, there are high uptakes of [123I]ADAM in the hippocampus, hypothalamus, striatum, olfactory tubercle, substantia nigra, dorsal raphe, median raphe, and thalamus, as in areas possessing known SERT. A hemiparkinsonisonisum was induced by injection of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle of rats. Two weeks later, methamphetamine-induced rotation behavior was evaluated. We choose three rats that performed drug-induced rotation over 300 circles. We also examined dopaminergic neurons in hemiparkinsonian rats by tyrosine hydroxylase immunohistochemistry which showed decreased dopaminergic neurons in the substantia nigra of hemiparkinsonian rats. The autoradiographical images also demonstrated that the [123I]ADAM uptakes in the hippocampus, hypothalamus, striatum, olfactory tubercle, dorsal raphe, median raphe, and thalamus of hemiparkinsonian rats were significantly lower than those of normal rats. In conclusion, we proposed that the novel ligand [123I]ADAM can be highly selective for SERT. Through this high selective radioligand [123I]ADAM, a significant decreased the serotonin transporters in several brain tissues was found in hemiparkinsonian rats.
author2 Jiang-Chuan, Liu
author_facet Jiang-Chuan, Liu
Hui-Ling,Huang
黃惠伶
author Hui-Ling,Huang
黃惠伶
spellingShingle Hui-Ling,Huang
黃惠伶
Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats
author_sort Hui-Ling,Huang
title Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats
title_short Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats
title_full Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats
title_fullStr Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats
title_full_unstemmed Biodistributions of [123I] ADAM in the Brain of Hemiparkinsonian Rats
title_sort biodistributions of [123i] adam in the brain of hemiparkinsonian rats
publishDate 2003
url http://ndltd.ncl.edu.tw/handle/89730871483160934480
work_keys_str_mv AT huilinghuang biodistributionsof123iadaminthebrainofhemiparkinsonianrats
AT huánghuìlíng biodistributionsof123iadaminthebrainofhemiparkinsonianrats
AT huilinghuang dāncèbājīnsēnshìzhèngdàbáishǔnǎozhōngzhī123iadamshēngwùfēnbùqíngxíng
AT huánghuìlíng dāncèbājīnsēnshìzhèngdàbáishǔnǎozhōngzhī123iadamshēngwùfēnbùqíngxíng
_version_ 1718317024580468736